Richard W Pascoe Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard W Pascoe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard W Pascoe. Richard W Pascoe is Senior VP, COO in ARIAD PHARMACEUTICALS INC ($ARIA) and SVP, Chief Commerical Officer in ARIAD PHARMACEUTICALS INC ($ARIA) and VP, Chief Commercial Officer in ARIAD PHARMACEUTICALS INC ($ARIA) and CEO & Secretary in APRICUS BIOSCIENCES, INC. ($APRI) and Director in SEELOS THERAPEUTICS, INC. ($APRI) and President, CEO & Director in Histogen Inc. ($CNAT) and See Remarks in Histogen Inc. ($CNAT) and Director in KEMPHARM, INC ($KMPH).
Latest Insider Trading Transactions of Richard W Pascoe
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, HSTO, KMPH, SEEL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | HSTO | Histogen Inc. | Pascoe Richard W | President, CEO & Di ... | Buy | P | 1.14 | 20,000 | 22,800 | 30,000 | 10 K to 30 K (+200.00 %) |
| Jan 15 2021 | CNAT | Histogen Inc. | Pascoe Richard W | President, CEO & Di ... | Option Exercise | A | 0.97 | 346,000 | 335,620 | 346,000 | |
| Dec 07 2020 | CNAT | Histogen Inc. | Pascoe Richard W | President, CEO & Di ... | Buy | P | 1.24 | 10,000 | 12,394 | 10,000 | 0 to 10 K |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Buy | P | 0.64 | 1,800 | 1,152 | 28,573 | 26.8 K to 28.6 K (+6.72 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Buy | P | 0.64 | 1,000 | 635 | 26,773 | 25.8 K to 26.8 K (+3.88 %) |
| Aug 18 2020 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Buy | P | 0.63 | 7,200 | 4,565 | 25,773 | 18.6 K to 25.8 K (+38.77 %) |
| Jun 22 2020 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 0.27 | 30,000 | 8,130 | 30,000 | |
| May 28 2020 | CNAT | Histogen Inc. | Pascoe Richard W | See Remarks | Option Exercise | J | 5.30 | 194,071 | 1,028,576 | 194,071 | |
| May 28 2020 | CNAT | Histogen Inc. | Pascoe Richard W | See Remarks | Option Exercise | J | 5.30 | 291,107 | 1,542,867 | 291,107 | |
| Jan 07 2020 | SEEL | SEELOS THERAPEUTIC ... | Pascoe Richard W | Director | Option Exercise | A | 1.42 | 16,000 | 22,720 | 16,000 | |
| May 14 2019 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Grant | A | 0.00 | 9,645 | 0 | 9,645 | 0 to 9.6 K |
| Apr 26 2019 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 1.62 | 30,000 | 48,600 | 30,000 | |
| Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | Pascoe Richard W | Director | Option Exercise | A | 2.33 | 16,000 | 37,280 | 16,000 | |
| Jan 24 2019 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 0.23 | 44,810 | 10,149 | 155,396 | 200.2 K to 155.4 K (-22.38 %) |
| Nov 30 2018 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 0.31 | 17,290 | 5,291 | 200,206 | 217.5 K to 200.2 K (-7.95 %) |
| May 24 2018 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 6.10 | 15,000 | 91,500 | 15,000 | |
| Jan 03 2018 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Option Exercise | A | 2.11 | 245,000 | 516,950 | 245,000 | |
| Jan 03 2018 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 1.84 | 7,679 | 14,129 | 217,496 | 225.2 K to 217.5 K (-3.41 %) |
| Sep 07 2017 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 1.56 | 18,790 | 29,312 | 225,175 | 244 K to 225.2 K (-7.70 %) |
| Jun 05 2017 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Grant | A | 0.00 | 100,000 | 0 | 243,965 | 144 K to 244 K (+69.46 %) |
| May 24 2017 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 3.95 | 10,000 | 39,500 | 10,000 | |
| Mar 24 2017 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 2.78 | 3,712 | 10,319 | 143,965 | 147.7 K to 144 K (-2.51 %) |
| Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Grant | A | 0.00 | 100,000 | 0 | 147,677 | 47.7 K to 147.7 K (+209.74 %) |
| May 26 2016 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 6.05 | 10,000 | 60,500 | 10,000 | |
| Apr 27 2016 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Grant | A | 0.00 | 350,000 | 0 | 476,778 | 126.8 K to 476.8 K (+276.07 %) |
| Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Option Exercise | A | 1.11 | 500,000 | 555,000 | 500,000 | |
| Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Grant | A | 0.00 | 79,778 | 0 | 126,778 | 47 K to 126.8 K (+169.74 %) |
| Aug 27 2015 | KMPH | KEMPHARM, INC | Pascoe Richard W | Director | Option Exercise | A | 19.02 | 10,000 | 190,200 | 10,000 | |
| Apr 15 2008 | ARIA | ARIAD PHARMACEUTIC ... | Pascoe Richard W | Senior VP, COO | Option Exercise | A | 0.00 | 61,000 | 0 | 61,000 | |
| Jul 02 2007 | ARIA | ARIAD PHARMACEUTIC ... | Pascoe Richard W | SVP, Chief Commeric ... | Option Exercise | A | 5.49 | 25,000 | 137,250 | 25,000 | |
| Apr 18 2007 | ARIA | ARIAD PHARMACEUTIC ... | Pascoe Richard W | VP, Chief Commercia ... | Option Exercise | A | 4.49 | 80,000 | 359,200 | 80,000 | |
| Dec 16 2005 | ARIA | ARIAD PHARMACEUTIC ... | Pascoe Richard W | VP, Chief Commercia ... | Option Exercise | A | 6.04 | 75,000 | 453,000 | 75,000 |
Page: 1